Evidence map›Paper›PMID 11369783›Full record

ArticleThe Journal of experimental medicine2001

Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: implications for autoimmunity.

A R Hamad, A Srikrishnan, P Mirmonsef, C P Broeren, C H June, D Pardoll, J P Schneck

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Distinct CD4Frontiers in immunology · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

A R HamadDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. ahamad@jhmi.edu
A Srikrishnan
P Mirmonsef
C P Broeren
C H June
D Pardoll
J P Schneck
Johns Hopkins University · USUniversity of Pennsylvania · USUtrecht University · NL

Funding

ANTIGEN SPECIFIC MODULATION OF T CELL RESPONSESR01AI044129 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SCHNECK, JONATHAN P · 1999 to 2009
$3.0M
NIAID NIH HHS AI2975-05NIAID NIH HHS AI44129NIAID NIH HHS R01 AI044129
6 · The paper itself

Abstract

Lymphoproliferative diseases are characterized by massive accumulation of CD4(-)CD8(-)B220(+) (double-negative [DN]) T cells in peripheral organs. Although evidence indicates these cells are derived from mature autoreactive alpha/beta T cells, the significance of coreceptor downregulation is not known. In this study, we examined the role CD4 coreceptor plays in the survival of repeatedly stimulated T cells. CD4(+/+) and CD4(-/-) T cells from AND T cell receptor (TCR) transgenic mice exhibited similar phenotypes after antigenic stimulation, but the CD4(-/-) T cells survived in much larger numbers than the CD4(+/+) cells upon primary and secondary major histocompatibility complex (MHC)/peptide stimulation. Enhanced survival of CD4(-/-) T cells was due to decreased apoptosis rather than enhanced proliferation. Similarly, circumvention of the CD4/MHC interaction by using a surrogate TCR ligand that does not engage CD4 led to significant enhancement of CD4(+/+) cells than when stimulated with MHC/peptide. Finally, we generated DN B220(+) T cells using an in vitro model system and showed they were more tolerant to chronic stimulation than CD4(+/+) cells. Together, these results indicate that coreceptor engagement controls expansion of normal T cells. In the absence of coreceptor, T cells survive chronic stimulation and express B220 as seen in autoimmune lymphoproliferative diseases.

Indexed as

Receptors, Antigen, T-Cell, alpha-betaAnimalsApoptosisAutoimmunityCD3 ComplexCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell SurvivalLeukocyte Common AntigensLymphocyte ActivationLymphoproliferative DisordersMiceMice, TransgenicReceptors, ImmunologicT-Lymphocyte SubsetsCD3 ComplexLeukocyte Common AntigensReceptors, Antigen, T-Cell, alpha-betaReceptors, Immunologic

Identifiers

PMID11369783
PMCPMC2193322
OpenAlexW2126924643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.